Ashurst has advised Jefferies as sponsor to PureTech Health plc in connection with potential further disposals of common stock in Karuna Therapeutics, Inc., a NASDAQ listed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
